Correction: ChromoGenics discloses order intake for the third quarter 2023
ChromoGenics AB submits this correction as the previous announcemnet today was missding the MAR label. The message should have included the following text: This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 18th October, at 11:20 CET.ChromoGenic's order intake for the third quarter of 2023 amounts to SEK 8.3 million, a considerably higher level than the previous quarter. "It is very gratifying that the